The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
Open accessAbstract
In the recent past the standard treatment of kala-azar involved the use of pentavalent antimonials Sb(V). Because of progressive rise in treatment failure to Sb(V) was limited its use in the treatment program in the Indian subcontinent. Until now the mechanism of action of Sb(V) is not very clear. Recent studies indicated that both parasite and hosts contribute to the antimony efflux mechanism. Interestingly, antimonials show strong immunostimulatory abilities as evident from the upregulation of transplantation antigens and enhanced T cell stimulating ability of normal antigen presenting cells when treated with Sb(V)in vitro. Recently, it has been shown that some of the peroxovanadium compounds have Sb(V)-resistance modifying ability in experimental infection with Sb(V) resistant Leishmania donovani isolates in murine model. Thus, vanadium compounds may be used in combination with Sb(V) in the treatment of Sb(V) resistance cases of kala-azar.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Haldar, A. K., Yadav, V., Singhal, E., Bisht, K. K., Singh, A., Bhaumik, S., Basu, R., Sen, P., & Roy, S. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000907 · Cited by 40
Self-citationRetractedMeister, A., & Anderson, M. E. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.003431 · Cited by 5,680
The burden of oral disease: challenges to improving oral health in the 21st century.
Petersen, P. E. (2005) · Europe PMC (PubMed Central) · Cited by 3,575
Drug Resistance in Leishmaniasis
Croft, S. L., Sundar, S., & Fairlamb, A. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.111-126.2006 · Cited by 1,663
Altered immune responses in mice lacking inducible nitric oxide synthase
Wei, X.-Q., Charles, I. G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Xu, D., Mullers, W., Moncada, S., & Liew, F. Y. (1995) · Nature · doi:10.1038/375408a0 · Cited by 1,292
Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
Croft, S. L., & Coombs, G. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.008 · Cited by 891
METABOLISM AND FUNCTIONS OF TRYPANOTHIONE IN THE KINETOPLASTIDA
Fairlamb, A. H., & Cerami, A. (1992) · Annual Review of Microbiology · doi:10.1146/annurev.mi.46.100192.003403 · Cited by 768
Leishmania and human immunodeficiency virus coinfection: the first 10 years
Alvar, J., Cañavate, C., Gutiérrez-Solar, B., Jiménez, M., Laguna, F., López-Vélez, R., Molina, R., & Moreno, J. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.2.298 · Cited by 736
Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l -arginine.
Liew, F. Y., Millott, S., Parkinson, C., Palmer, R. M. J., & Moncada, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.12.4794 · Cited by 736
Vanadium Compounds as Insulin Mimics
Thompson, K. H., McNeill, J. H., & Orvig, C. (1999) · Chemical Reviews · doi:10.1021/cr980427c · Cited by 692
Sundar, S., More, D. K., Singh, M. K., Singh, V. P., Sharma, S., Makharia, A., Kumar, P. C. K., & Murray, H. W. (2000) · Clinical Infectious Diseases · doi:10.1086/318121 · Cited by 664
Evangelou, A. M. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00221-9 · Cited by 612
Drug resistance in Indian visceral leishmaniasis
Sundar, S. (2001) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2001.00778.x · Cited by 585
Posner, B. I., Faure, R., Burgess, J. W., Bevan, A. P., Lachance, D., Zhang-Sun, G., Fantus, I. G., Ng, J. B., Hall, D. A., & Lum, B. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41818-7 · Cited by 532
Pentavalent Antimonials: New Perspectives for Old Drugs
Frézard, F., Demicheli, C., & Ribeiro, R. R. (2009) · Molecules · doi:10.3390/molecules14072317 · Cited by 496
Olivier, M., Gregory, D. J., & Forget, G. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.293-305.2005 · Cited by 493
Injectable Paromomycin for Visceral Leishmaniasis in India
Sundar, S., Jha, T. K., Thakur, C. P., Sinha, P. K., & Bhattacharya, S. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066536 · Cited by 471
Interleukin 10 production correlates with pathology in human Leishmania donovani infections.
Ghalib, H. W., Piuvezam, M. R., Skeiky, Y. A., Siddig, M., Hashim, F. A., el-Hassan, A. M., Russo, D. M., & Reed, S. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116570 · Cited by 434
Murray, H. W., & Nathan, C. F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.741 · Cited by 418
Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism
Krauth-Siegel, R. L., & Comini, M. A. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.03.006 · Cited by 414
Microtubules and signal transduction
Gundersen, G. G., & Cook, T. A. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80010-6 · Cited by 407
Leishmania/HIV co-infections: epidemiology in Europe
Desjeux, P., & Alvar, J. (2003) · Annals of Tropical Medicine & Parasitology · doi:10.1179/000349803225002499 · Cited by 398
Chemotherapy for Leishmaniasis: Biochemical Mechanisms, Clinical Efficacy, and Future Strategies
Berman, J. D. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.3.560 · Cited by 380
Croft, S., & Yardley, V. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023396258 · Cited by 380
Urbatsch, I. L., Sankaran, B., Weber, J., & Senior, A. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19383 · Cited by 363
Karp, C. L., el-Safi, S. H., Wynn, T. A., Satti, M. M., Kordofani, A. M., Hashim, F. A., Hag-Ali, M., Neva, F. A., Nutman, T. B., & Sacks, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116372 · Cited by 340
Challenges and new discoveries in the treatment of leishmaniasis
Singh, S., & Sivakumar, R. (2004) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-004-0348-9 · Cited by 293
Drug resistance in leishmaniasis
Chakravarty, J., & Sundar, S. (2010) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.62887 · Cited by 270
Phase 4 Trial of Miltefosine for the Treatment of Indian Visceral Leishmaniasis
Bhattacharya, S. K., Sinha, P. K., Sundar, S., Thakur, C. P., Jha, T. K., Pandey, K., Das, V. R., Kumar, N., Lal, C., Verma, N., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/519690 · Cited by 261
The Leishmania ATP-binding Cassette Protein PGPA Is an Intracellular Metal-Thiol Transporter ATPase
Légaré, D., Richard, D., Mukhopadhyay, R., Stierhof, Y.-D., Rosen, B. P., Haimeur, A., Papadopoulou, B., & Ouellette, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102351200 · Cited by 242
Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.
Mukhopadhyay, R., Dey, S., Xu, N., Gage, D., Lightbody, J., Ouellette, M., & Rosen, B. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10383 · Cited by 238
Rosen, B. P. (2002) · Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology · doi:10.1016/s1095-6433(02)00201-5 · Cited by 231
Kaye, P. M., Curry, A. J., & Blackwell, J. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.8.2763 · Cited by 223
Molecular mechanisms of antimony resistance in Leishmania
Ashutosh, Sundar, S., & Goyal, N. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46841-0 · Cited by 222
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
PEREZVICTORIA, F., SANCHEZCANETE, M., SEIFERT, K., CROFT, S., SUNDAR, S., CASTANYS, S., & GAMARRO, F. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.04.001 · Cited by 211
Sundar, S., Rai, M., Chakravarty, J., Agarwal, D., Agrawal, N., Vaillant, M., Olliaro, P., & Murray, H. W. (2008) · Clinical Infectious Diseases · doi:10.1086/591972 · Cited by 209
Mukherjee, S. B., Das, M., Sudhandiran, G., & Shaha, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201961200 · Cited by 207
In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs
Seifert, K., & Croft, S. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.73-79.2006 · Cited by 207
Ovothiol and trypanothione as antioxidants in trypanosomatids
Ariyanayagam, M. (2001) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(01)00285-7 · Cited by 192
Grondin, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3057 · Cited by 188
Mookerjee Basu, J., Mookerjee, A., Sen, P., Bhaumik, S., Sen, P., Banerjee, S., Naskar, K., Choudhuri, S. K., Saha, B., Raha, S., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1788-1797.2006 · Cited by 175
Self-citationJha, T. K., Olliaro, P., Thakur, C. P. N., Kanyok, T. P., Singhania, B. L., Singh, I. J., Singh, N. K. P., Akhoury, S., Jha, S., & Lockwood, D. N. J. (1998) · BMJ · doi:10.1136/bmj.316.7139.1200 · Cited by 170
Sudhandiran, G., & Shaha, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301975200 · Cited by 168
Design of vanadium compounds as insulin enhancing agents
Thompson, K. H., & Orvig, C. (2000) · Journal of the Chemical Society, Dalton Transactions · doi:10.1039/b002753g · Cited by 166
Blanchette, J., Racette, N., Faure, R., Siminovitch, K. A., & Olivier, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3737::aid-immu3737>3.0.co;2-s · Cited by 161
Zhou, Y., Messier, N., Ouellette, M., Rosen, B. P., & Mukhopadhyay, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404383200 · Cited by 161
An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae.
Dey, S., Ouellette, M., Lightbody, J. J., Papadopoulou, B., & Rosen, B. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2192 · Cited by 157
DENTON, H., McGregor, J. C., & Coombs, G. H. (2004) · Biochemical Journal · doi:10.1042/bj20040283 · Cited by 155
Nandan, D., Yi, T., Lopez, M., Lai, C., & Reiner, N. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209210200 · Cited by 154
Fadili, K. E., Messier, N., Leprohon, P., Roy, G., Guimond, C., Trudel, N., Saravia, N. G., Papadopoulou, B., Légaré, D., & Ouellette, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1988-1993.2005 · Cited by 149
Tsiani, E., & Fantus, I. G. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(96)00262-7 · Cited by 139
Rakotomanga, M., Saint-Pierre-Chazalet, M., & Loiseau, P. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2677-2686.2005 · Cited by 133
Haimeur, A., Guimond, C., Pilote, S., Mukhopadhyay, R., Rosen, B. P., Poulin, R., & Ouellette, M. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01634.x · Cited by 127
Miltefosine Promotes IFN-γ-Dominated Anti-Leishmanial Immune Response
Wadhone, P., Maiti, M., Agrawal-Rajput, R., Kamat, V., Martin, S., & Saha, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803859 · Cited by 125
Inhibition of Leishmanias But Not Host Macrophages by the Antitubulin Herbicide Trifluralin
Chan, M. M.-Y., & Fong, D. (1990) · Science · doi:10.1126/science.2392684 · Cited by 122
GRAMICCIA, M., Gradoni, L., & Orsini, S. (1992) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1992.11812717 · Cited by 121
Flohé, L., Budde, H., Bruns, K., Castro, H., Clos, J., Hofmann, B., Kansal-Kalavar, S., Krumme, D., Menge, U., Plank-Schumacher, K., et al. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2688 · Cited by 120
Guimond, C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg806 · Cited by 118
Lachaud, L., Bourgeois, N., Plourde, M., Leprohon, P., Bastien, P., & Ouellette, M. (2008) · Clinical Infectious Diseases · doi:10.1086/595710 · Cited by 118
Modulation of Interferon-γ-induced Macrophage Activation by Phosphotyrosine Phosphatases Inhibition
Olivier, M., Romero-Gallo, B.-J., Matte, C., Blanchette, J., Posner, B. I., Tremblay, M. J., & Faure, R. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13944 · Cited by 117
Murray, H. W., & Delph‐Etienne, S. (2000) · Infection and Immunity · doi:10.1128/iai.68.1.288-293.2000 · Cited by 117
Role and effect of IL-2 in experimental visceral leishmaniasis.
Murray, H. W., Miralles, G. D., Stoeckle, M. Y., & McDermott, D. F. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.2.929 · Cited by 110
Zinc fingers: DNA binding and protein-protein interactions
León, Ó., & Roth, M. J. (2000) · Biological Research · doi:10.4067/s0716-97602000000100009 · Cited by 110
Herman, J. D., Gallalee, J. V., & Best, J. M. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90689-7 · Cited by 105
Interaction of antimony tartrate with the tripeptide glutathione
Sun, H., Yan, S., & Cheng, W. S. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01605.x · Cited by 103
Weise, F., Stierhof, Y., Kühn, C., Wiese, M., & Overath, P. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4587 · Cited by 99
Thakur, C. P., Kumar, M., Kumar, P., Mishra, B. N., & Pandey, A. K. (1988) · BMJ · doi:10.1136/bmj.296.6636.1557 · Cited by 99
Inhibition of ABC Transporters Abolishes Antimony Resistance inLeishmaniaInfection
Basu, J. M., Mookerjee, A., Banerjee, R., Saha, M. C., Singh, S. K., Naskar, K., Tripathy, G., Sinha, P. K., Pandey, K., Sundar, S., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01196-07 · Cited by 96
Self-citationRusso, R., Nigro, L., Minniti, S., Montineri, A., Gradoni, L., Caldeira, L., & Davidson, R. N. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)91343-2 · Cited by 94
In Vitro Flow Cytometry Method to Quantitatively Assess Inhibitors of P-Glycoprotein
Wang, E., Casciano, C. N., Clement, R. P., & Johnson, W. W. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15095-7 · Cited by 87
pH homeostasis in Leishmania donovani amastigotes and promastigotes.
Glaser, T. A., Baatz, J. E., Kreishman, G. P., & Mukkada, A. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7602 · Cited by 86
Barbeau, B., Bernier, R., Dumais, N., Briand, G., Olivier, M., Faure, R. L., Posner, B. I., & Tremblay, M. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.12968 · Cited by 83
Nandan, D., & Reiner, N. E. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.07.017 · Cited by 76
Wyllie, S., & Fairlamb, A. H. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.043 · Cited by 76
Haimeur, A., Conseil, G., Deeley, R. G., & Cole, S. P. C. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1375 · Cited by 75
Relapse of Visceral Leishmaniasis after Miltefosine Treatment in a Nepalese Patient
Pandey, B. D., Pandey, K., Kaneko, O., et al. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.580 · Cited by 74
Comparison of regimens of treatment with sodium stibogluconate in kala-azar.
Thakur, C. P., Kumar, M., Singh, S. K., Sharma, D., Prasad, U., Singh, R. S., Dhawan, P. S., & Achari, V. (1984) · BMJ · doi:10.1136/bmj.288.6421.895 · Cited by 73
Drug resistance mechanisms in clinical isolates of Leishmania donovani.
Singh, N. (2006) · PubMed · Cited by 73
Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs
Yi, T., Pathak, M. K., Lindner, D. J., Ketterer, M. E., Farver, C. F., & Borden, E. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5978 · Cited by 70
Vouldoukis, I., Drapier, J., Nussler, A. K., Tselentis, Y., Silva, O. A. D., Gentilini, M., Mossalayi, D. M., Monjour, L., & Dugas, B. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.253 · Cited by 69
Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling
Mann, K. K., Davison, K. L., Colombo, M., Colosimo, A. L., Diaz, Z., Padovani, A. M. S., Guo, Q., Scrivens, P. J., Gao, W., Mader, S., et al. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.06.017 · Cited by 67
Jang, J.-H., & Surh, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406371200 · Cited by 65
Trypanothione S-Transferase Activity in a Trypanosomatid Ribosomal Elongation Factor 1B
Vickers, T. J., & Fairlamb, A. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311039200 · Cited by 63
Peroxiredoxins in antioxidant defense and redox regulation
Flohé, L., Budde, H., & Hofmann, B. (2003) · BioFactors · doi:10.1002/biof.5520190102 · Cited by 58
Glutathione S-transferase π in an arsenic-resistant Chinese hamster ovary cell line
Lo, J. F., Wang, H. F., Tam, M. F., & Lee, T. (1992) · Biochemical Journal · doi:10.1042/bj2880977 · Cited by 54
Pérez-Victoria, J. M., Pérez‐Victoria, F. J., Conseil, G., Maitrejean, M., Comte, G., Barron, D., Pietro, A. D., Castanys, S., & Gamarro, F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.439-446.2001 · Cited by 49
Nabors, G. S., & Farrell, J. P. (1994) · Infection and Immunity · doi:10.1128/iai.62.12.5498-5504.1994 · Cited by 42
Cortés-Selva, F., Jiménez, I. A., Muñoz‐Martínez, F., Campillo, M., Bazzocchi, I. L., Pardo, L., RAVELO, A. G., Castanys, S., & Gamarro, F. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054864920 · Cited by 42
Gainey, D., Short, S., & McCoy, K. L. (1996) · Journal of Cellular Physiology · Cited by 40
Lecureur, V., Lagadic‐Gossmann, D., & Fardel, O. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.5.1071 · Cited by 39
Involvement of thiol metabolism in resistance to glucantime in leishmania tropica
Arana, F. E., Pérez-Victoria, J. M., Repetto, Y., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00129-4 · Cited by 36
Berman, J. D., Gallalee, J. V., & Hansen, B. D. (1987) · Experimental Parasitology · doi:10.1016/0014-4894(87)90018-x · Cited by 30
[Childhood Mediterranean visceral leishmaniasis].
Cascio, A., & Colomba, C. (2003) · PubMed · Cited by 15
First five years in practice. Finding resources and space to work.
Robson, J. P. (1984) · BMJ · doi:10.1136/bmj.288.6413.295 · Cited by 7
Cited by
The elements of life and medicines
Chellan, P., & Sadler, P. J. (2015) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2014.0182 · Cited by 274
Rodrigues, L. S., Barreto, A. S., Bomfim, L. G. S., Gomes, M. C., Ferreira, N. L. C., da Cruz, G. S., Magalhães, L. S., de Jesus, A. R., Palatnik-de-Sousa, C. B., Corrêa, C. B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.773983 · Cited by 44
Use of Microbial Consortia in Bioremediation of Metalloid Polluted Environments
Lashani, E., Amoozegar, M. A., Turner, R. J., & Moghimi, H. (2023) · Microorganisms · doi:10.3390/microorganisms11040891 · Cited by 44
van der Woude, M., Davó-Martínez, C., Thijssen, K. L., Vermeulen, W., & Lans, H. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad642 · Cited by 11
Metadata
- Authors
- Haldar, A. K., Sen, P., & Roy, S.
- Venue
- Molecular Biology International
- Publisher
- Wiley
- Published
- 2011-06-08
- Volume
- 2011
- Pages
- 1-23
- ISSN
- 2090-2182 (ISSN-L)
- 2090-2190
- OpenAlex
- W2125483721
- Cited by
- 408
- References
- 94
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.